Cargando…
Evaluation of the Live Biotherapeutic Product, Asymptomatic Bacteriuria Escherichia coli 2‐12, in Healthy Dogs and Dogs with Clinical Recurrent UTI
BACKGROUND: Antimicrobial resistance is an emerging problem. HYPOTHESIS/OBJECTIVE: To investigate the safety and efficacy of a live biotherapeutic product, ASB E. coli 2‐12 for UTI treatment. ANIMALS: Six healthy research dogs; nine client‐owned dogs with recurrent UTI. METHODS: Prospective noncontr...
Autores principales: | Segev, G., Sykes, J.E., Klumpp, D.J., Schaeffer, A.J., Antaki, E.M., Byrne, B.A., Yaggie, R.E., Westropp, J.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787194/ https://www.ncbi.nlm.nih.gov/pubmed/29243301 http://dx.doi.org/10.1111/jvim.14851 |
Ejemplares similares
-
Asymptomatic Bacteriuria Escherichia coli Are Live Biotherapeutics for UTI
por: Rudick, Charles N., et al.
Publicado: (2014) -
Evaluation of a rapid immunoassay for bacteriuria in dogs
por: Sutter, Craig M., et al.
Publicado: (2023) -
Antimicrobial Susceptibility Patterns in Urinary Tract Infections in Dogs (2010–2013)
por: Wong, C., et al.
Publicado: (2015) -
The Frequency and Clinical Implications of Bacteriuria in Chronically Paralyzed Dogs
por: Baigi, S.R., et al.
Publicado: (2017) -
Urinary Neutrophil Gelatinase‐associated Lipocalin as a Marker for Identification of Acute Kidney Injury and Recovery in Dogs with Gentamicin‐induced Nephrotoxicity
por: Palm, C.A., et al.
Publicado: (2016)